Category Archives: Psoriasis

Walk to Cure Psoriasis April 7 2013
South Florida Walk to Cure Psoriasis just completed its 7th year! Andrew Henschel is the Founder and Chairman of the South Florida Walk for the Cure. To date...

By: Karen Ann

Go here to read the rest:
Walk to Cure Psoriasis April 7 2013 - Video

Dubai: People who have psoriasis, a chronic skin condition marked by raised, red bumps covered with white, flaking scales, may feel stigmatised socially and emotionally, said specialists in dermatology on Wednesday.

Patients with psoriasis are prone to social discrimination and humiliation, and have an increased risk of depression, anxiety, fatigue, sleep impairment, and suicide, they said.

During the ongoing Dubai World Dermatology and Laser Conference and Exhibition Dubai Derma at Dubai International Convention and Exhibition Centre, which concludes on April 18, specialists spoke of how psoriasis can have a significant emotional toll on patients.

According to the international advocacy organisation National Psoriasis Foundation, psoriasis is a non-contagious, chronic, inflammatory, painful, disfiguring and disabling disease for which there is no cure.

Article continues below

The organisations research links patients with psoriasis as feeling self-conscious and embarrassed. It also links the condition to social discrimination and humiliation.

Speaking to Gulf News on the psychosocial impact of psoriasis, Dr Anwar Al Hammadi, Consultant and Head of Dermatology at the Dubai Health Authority (DHA) and chairperson of the conference said that apart from the physical impact, psoriasis can have adverse emotional effects, leading to a cycle of despair.

Some patients are unable to cope because the condition has no cure, often resulting in depression and anxiety. They may feel stigmatised when rejected due to their skin disease in various settings and among family members. The social isolation further impacts levels of physical activity, increasing the risk of obesity and other related complicatons, he said.

Dr Al Hammadi stressed the importance of family, social and emotional support for patients. He explained that patients with psoriasis need support to help them deal with the adverse effects of the condition.

The lack of knowledge and misunderstanding about the disorder adds to the stigma and emotional stress. Treatment involves topical creams, oral therapy and/or phototherapy, he said.

See the original post here:
People with psoriasis suffer social stigma

Emotional scar weighs psoriasis patients down

Staff Reporter / 18 April 2013

A significant percentage of people afflicted with psoriasis, a severe skin condition, suffer from the emotional impact of the disease, said a top dermatologist at the Dubai Derma 2013 conference which is taking place at Dubai World Trade Centre.

Dr Anwar Al Hammadi, chairperson of the conference and head of dermatology at the Dubai Health Authority (DHA), said because large patchy flakes and skin flare-ups can be seen in patients with the disease, many of them are conscious of the disease and do not properly integrate themselves in society.

In 2012, of the 12,000 patient visits at the DHA dermatology centre, 966 patients had psoriasis. Of them, 1.2 per cent were new patients and 7.3 per cent were follow-up patients: In terms of the UAE, we still are within the worldwide range in terms of prevalence of the disease. However, I would advocate awareness as a means to tackle this problem and early intervention for better patient outcomes, Dr Al Hammadi said.

According to the American hospital Johns Hopkins, psoriasis is a persistent skin disorder characterised by patches of raised, red bumps covered with white, flaking scales. It generally develops on the scalp, knees, or elbows, although it may affect any area of the skin. The production of skin cells at affected sites is accelerated, and the accumulation of excess cells causes scaly plaques. First attacks usually begin between the ages of 10 and 30.

While psoriasis cannot be cured, its symptoms can be greatly controlled, providing relief for patients. However, early intervention is important for the management of the disease, Dr Al Hammadi said.

He also said that people who are obese and have psoriasis, tend to have stronger symptoms of the disease and thus healthy eating and weightloss are important in the fight against the disease.

Latest research shows that psoriasis is a systematic disease which means that patients with the disease are at a higher risk of developing high blood pressure, diabetes etc and regular health checks are important, he added.

He also said that if one parent has the disease, the chances of children developing it is 17 per cent, but if both parents have the disease, the chances are 42 per cent.

Read more:
Emotional scar weighs psoriasis patients down

NEW YORK, April 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

http://www.reportlinker.com/p01158447/EpiCast-Report-Psoriasis---Epidemiology-Forecast-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

Summary

Psoriasis is an immune-mediated chronic disorder of the skin characterized by redness and irritation. It affects people of both sexes and of all ages and races/ethnicities. The global prevalence of psoriasis varies geographically, with the disease being more prevalent in the colder areas of the north, and less prevalent in the tropics and warmer regions of the world (Weller et al., 2008). In European countries, psoriasis is more prevalent in residents of the colder central regions and less prevalent in residents of the southern regions. In some Asian countries, such as India, the prevalence of psoriasis is highest in the northern parts of the country. In contrast to India, China shows no difference in prevalence between the northern and southern regions (Bedi, 1995; Ding et al., 2012; Kawada et al., 2003; Naldi et al., 2004; Saraceno et al., 2006). In addition to the north-to-south prevalence gradient observed within most countries, the prevalence of psoriasis also varies among different countries. Globally, the prevalence of psoriasis varies from as low as 0.03% in Japan to as high as 3.15% in the US (Ding et al., 2012; Kawada et al., 2003). Differences in the reported prevalence between countries may be attributable to variations in environmental factors, genetic factors, and differences in the case definition used to diagnose psoriasis in epidemiology studies (Bedi, 1995; Ding et al., 2012; Gelfand et al., 2005b).

Scope

- The Psoriasis EpiCast Report provides an overview of the risk factors and global trends of psoriasis in the nine major markets (the US, France, Germany, Italy, Spain, the UK, Japan, China, and India). - It includes a 10-year epidemiology forecast of the prevalent cases of psoriasis segmented by sex and age (by five-year increments, beginning at age 15 years and ending at =85 years) in the 9MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global psoriasis market. - Quantify patient populations in the global psoriasis market to improve product design, pricing, and launch plans. - Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for psoriasis therapeutics in each of the markets covered.

Follow this link:
EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

Psoriasis No More Review Discount
Visit http://ignmmulia3.psoriasis3.hop.clickbank.net Psoriasis No More Review Discount WARNING: Psoriasis Does NOT Have To Be A Part Of Your Life! Long Tim...

By: Brinegar Bacticeived

See the original post:
Psoriasis No More Review

My Natural Hair! Psoriasis talk! ACV Rinse talk!
Just wanted to share what #39;s under the wig with you guys!!! A little bit on what I use and some details on my scalp condition! XOXO.

By: TheeBrittanyShow

Follow this link:
My Natural Hair! Psoriasis talk! ACV Rinse talk! - Video

Dermatology Pt 2 - Mouth ulcers, Warts, Psoriasis, Inertigo Remedies
Dermatology Pt 2. Learn the various home and natural remedies for treatment of Mouth ulcers, Warts, Psoriasis, Inertigo Remedies.

By: samkadya

Here is the original post:
Dermatology Pt 2 - Mouth ulcers, Warts, Psoriasis, Inertigo Remedies - Video

How to Psoriasis Treatment - Skin Disorder
Psoriasis treatment - Skin Disorders - Eczema - Acne http://www.mento-neeminternational.com A skin disorder is a disorder or disease that affects the skin. T...

By: MentoNeem

Link:
How to Psoriasis Treatment - Skin Disorder - Video

Scalp Psoriasis Treatment
http://tinyurl.com/d8yrgqk More info here! Scalp Psoriasis Treatment How To Permanently Eliminate Psoriasis? Psoriasis symptoms like scalp psoriasis, Eczema,...

By: Scalppsoriasis2

Continue reading here:
Scalp Psoriasis Treatment - Video

DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2013" report to their offering.

Global Markets Direct's, 'Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris). Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Plaque Psoriasis (Psoriasis Vulgaris).

- A review of the Plaque Psoriasis (Psoriasis Vulgaris) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

The rest is here:
Research and Markets: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2013